We are live on ! Find out more
YCM

Yiheng Capital Management Portfolio holdings

AUM $231M
1-Year Est. Return 29.07%
This Fund
S&P 500
This Quarter Est. Return
+11.18%
1 Year Est. Return
+29.07%
3 Year Est. Return
+63.69%
5 Year Est. Return
+56.64%
10 Year Est. Return
+851.36%
AUM
$1.62B
AUM Growth
-$129M
Cap. Flow
+$199M
Cap. Flow %
12.26%
Top 10 Hldgs %
77.31%
Holding
39
New
4
Increased
8
Reduced
9
Closed
3

Top Buys

Rank Stock Value
1
SABR icon
Sabre
SABR
+$20.6M
2
BILI icon
Bilibili
BILI
+$16.2M
3
VRDN icon
Viridian Therapeutics
VRDN
+$6.71M
4
AKRO
Akero Therapeutics
AKRO
+$3.31M
5
NOAH
Noah Holdings
NOAH
+$491K

Top Sells

Rank Stock Value
1
ACMR icon
ACM Research
ACMR
+$80.7M
2
GBT
Global Blood Therapeutics, Inc.
GBT
+$48M
3
ZH
Zhihu
ZH
+$19.8M
4
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$19M
5
JD icon
JD.com
JD
+$17.8M

Sector Composition

Rank Sector Weight
1 Healthcare 13.3%
2 Consumer Discretionary 12.29%
3 Communication Services 12.11%
4 Technology 8.26%
5 Industrials 7.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NIU
26
Niu Technologies
NIU
$193M
$4.77M 0.29%
1,162,675
– –
ACMR icon
27
ACM Research
ACMR
$5.79B
$3.77M 0.23%
302,300
-4,964,500
-94% -$80.7M
VIPS icon
28
Vipshop
VIPS
$7.53B
$3.08M 0.19%
366,825
– –
AKRO
29
CALL
DELISTED
Akero Therapeutics
AKRO
$2.58M 0.16%
+75,800
New +$1.16M
SQNS
30
Sequans Communications SA
SQNS
$41.3M
$2.09M 0.13%
23,370
– –
VISN
31
Vistance Networks Inc
VISN
$2.52B
$1.84M 0.11%
200,004
– –
MYND
32
Mynd.ai
MYND
$19.3M
$770K 0.05%
137,455
– –
NOAH
33
CALL
Noah Holdings
NOAH
$603M
$382K 0.02%
+28,900
New +$491K
RERE
34
ATRenew
RERE
$1.01B
$376K 0.02%
163,476
-4,030,588
-96% -$11.2M
AIU
35
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
$325K 0.02%
63,108
– –
JT
36
DELISTED
Jianpu Technology Inc. American Depositary Shares, each representing twenty Class A Ordinary Shares
JT
$42K ﹤0.01%
25,702
– –
HTHT icon
37
CALL
Huazhu Hotels Group
HTHT
$13B
– –
-785,700
Closed -$29.9M
SABR icon
38
CALL
Sabre
SABR
$835M
– –
-2,457,100
Closed -$14.3M
GBT
39
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-1,501,382
Closed -$48M
1
2

Similar funds

PWA
Prairie Wealth Advisors Omaha, Nebraska $231M AUM 23.67% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
RF
rebel Financial Groveport, Ohio $231M AUM 12.5% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
WF
Wayfinding Financial Lynnwood, Washington $230M AUM 17.64% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
TRIA
Trail Ridge Investment Advisors Fort Collins, Colorado $230M AUM 22.34% 1-Year Est. Return
SCM
Soros Capital Management New York $230M AUM 83.9% 1-Year Est. Return

Yiheng Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Yiheng Capital Management held 39 positions worth $1.62B, down 7.4% from $1.75B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Yiheng Capital Management deployed $199M of net new capital in Q3 2022, opening 4 new positions and adding to 8 existing holdings. Its largest new stake was Viridian Therapeutics: 373,051 shares worth $7.65M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was ACM Research, an estimated $80.7M trimmed.

  • Yiheng Capital Management's largest Q3 2022 buy was Viridian Therapeutics: 373,051 shares worth $7.65M.
  • Yiheng Capital Management added most to Sabre in Q3 2022, an estimated $20.6M increase.
  • Yiheng Capital Management's biggest Q3 2022 reduction was ACM Research, cutting an estimated $80.7M.
  • Yiheng Capital Management fully exited Global Blood Therapeutics, Inc. in Q3 2022, selling an estimated $48M.
  • Yiheng Capital Management's ten largest holdings make up 77% of its $1.62B portfolio in Q3 2022.
  • Yiheng Capital Management opened 4 new positions and closed 3 in Q3 2022.
  • Yiheng Capital Management's portfolio value fell 7.4% quarter-over-quarter to $1.62B.

Based on Yiheng Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.